Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)
NCT05107193 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-11-08
Summary
Gene fusions are defined as two separate genes joined together (gene 1, gene 2), generating a novel fusion gene. NRG1 fusions are rare and complex with regard to the fusion/fusion partner. The specific NRG1 gene fusion will be identified by a specialized molecular testing lab.
Conditions
Interventions
- DRUG
-
afatinib
afatinib
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Collection of Tissue Samples for Study of Multidrug Resistance
NCT00880503 ·Status: COMPLETED
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
Integrated Molecular Profiling in Advanced Cancers Trial
NCT01505400 ·Status: ACTIVE_NOT_RECRUITING
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
NCT02213822 ·Status: UNKNOWN
-
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
NCT02199938 ·Status: TERMINATED
-
Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion
NCT04557813 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
NCT01493830 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Screening Study for Participants With Malignant Tumors
NCT05419375 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
NCT01345513 ·Status: COMPLETED
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
NCT00539318 ·Status: TERMINATED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
NCT01381705 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Biomarkers in Young Patients With Neuroblastoma
NCT01169376 ·Status: COMPLETED
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer
NCT01443390 ·Status: COMPLETED
-
An Observational Study to Learn More About NTRK Gene Fusion Positive in Solid Tumor in Japan
NCT05793281 ·Status: COMPLETED